Global Cell Separation and Characterization in Solid Tumors Market to Reach $3.3 Billion

December 26, 2018

WELLESLEY, Mass., Dec. 26, 2018 – Due to the inefficiency of traditional cancer treatments, increasing R&D in stem cell research, the relentless persistence of cancer, technological advancements and the dire need for a more targeted-based therapy, the global market for cell separation and characterization in solid tumors has expanded to meet consumer demand, according to the report “Cell Separation and Characterization in Solid Tumors: Global Markets Through 2023.”

The global market for cell separation and characterization in solid tumors was valued at $1.8 billion in 2018 and is expected to reach $3.3 billion by 2023 at a compound annual growth rate (CAGR) of 12.5%, according to BCC Research.

Major players in the industry include OncoStem Diagnostics Pvt. Ltd., F. Hoffmann-La Roche AG (RHHBY), Ariad Pharmaceuticals, Leica Microsystems, Cancer Research UK, Phenom-World, Daiichi Sankyo (DSKYF) and Takeda Pharmaceuticals (TKPHF).

Research Highlights:

By product, the cell separation and characterization in solid tumor market has been segmented into solid tumor kit, multi-marker solid tumor panels, reagents and microchips, and micro-beads (other).
Research institutes are established for doing research on a specific topic or are oriented to a specific field such as cancer, as well as other diseases and disorders. North America is expected to hold the largest share in the global academics sector.
The Asia-Pacific region is expected to emerge as the fastest-growing region for cell separation and characterization in the solid tumor market.

“Cell separation and characterization in solid tumors forms the basis for personalized medicine for cancer patients,” said BCC Research analyst Anuj Pathak. “The market has been gaining popularity across the globe due to its significant contribution in drug discovery and cancer diagnostics.”

Isolation of Solid Tumor Cells Within the In-Vitro Environment Presents Challenges

One of the primary factors hindering market growth is the isolation and characterization in solid tumor cells within an in vitro environment. It is challenging to grow and isolate these tumor cells that are similar to the microenvironment of the original tumor with in-vitro conditions.

Editors/reporters requesting analyst interviews should contact Eric Surber at press@bccresearch.com.

Cell Separation and Characterization in Solid Tumors: Global Markets Through 2023( BIO167A )
Publish Date: Dec 2018

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.